Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G GENMAB A/S Filed by: Darwin Global Management, Ltd.

October 5, 2026 9:30 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of (i) 1,825,006 Ordinary Shares and (ii) 18,433,047 ADSs representing 1,843,304 Ordinary Shares.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of (i) 1,825,006 Ordinary Shares and (ii) 18,433,047 ADSs representing 1,843,304 Ordinary Shares.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of (i) 1,775,809 Ordinary Shares and (ii) 17,939,370 ADSs representing 1,793,937 Ordinary Shares.


SCHEDULE 13G



Darwin Global Management, Ltd.
Signature:/s/ John Legge
Name/Title:John Legge, Director and Chief Financial Officer
Date:10/05/2026
Dr. Abhishek Trehan
Signature:/s/ Dr. Abhishek Trehan
Name/Title:Dr. Abhishek Trehan, individually
Date:10/05/2026
Darwin Global Master Fund, Ltd.
Signature:/s/ John Legge
Name/Title:By: Darwin Global Management, Ltd, its Investment Manager, By: John Legge, Director and Chief Financial Officer
Date:10/05/2026
Exhibit Information

Exhibit 99: Joint Filing Agreement

ATTACHMENTS / EXHIBITS

JOINT FILING AGREEEMENT

Categories

SEC Filings